Cytogenetics in CLL and related disorders

Area of Science:

• Cytogenetics
• Hematology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy.
• Chromosomal abnormalities are frequently observed in CLL and influence disease progression.
• Understanding these genetic alterations is crucial for diagnosis and prognosis.

Purpose of the Study:

• To analyze chromosomal abnormalities in a large cohort of CLL patients.
• To correlate specific chromosomal changes with clinical outcomes.
• To investigate chromosomal patterns in related lymphoid leukemias.

Main Methods:

• Analysis of chromosome banding and karyotyping data from over 1200 CLL patients.
• Review of reported cases from the International Working Party on Chromosomes in CLL and literature.
• Statistical correlation of chromosomal findings with patient prognosis.

Main Results:

• Clonal chromosomal aberrations found in approximately 50% of CLL patients.
• Trisomy 12 observed in one-third of patients with clonal aberrations.
• Common abnormalities include 13q14 deletions (retinoblastoma gene locus), 11q, and 6q deletions.
• 14q+ markers are frequent in advanced stages, often within complex rearrangements.
• Trisomy 12 as a sole abnormality is adverse; 13q abnormalities generally indicate a better prognosis.
• Similar chromosomal changes seen in lymphoid leukemias with monoclonal immunoglobulin secretion.
• Specific abnormalities noted in B-cell prolymphocytic leukemia (t(11;14), trisomy 12), T-cell prolymphocytic leukemia (inv(14)(q11;q32), trisomy 8q), and hairy cell leukemia (inv(5)9).

Conclusions:

• The number and type of clonal chromosomal abnormalities in CLL have significant prognostic value.
• Specific genetic alterations, such as trisomy 12 and 13q deletions, are key indicators of patient outcomes.
• Chromosomal analysis provides critical insights into the biology and clinical behavior of CLL and related leukemias.